NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tanvex BioPharma Inc (TW: 6541)

 
6541 Technical Analysis
4
As on 10th Dec 2025 6541 STOCK Price closed @ 58.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 59.54 & Strong Sell for SHORT-TERM with Stoploss of 66.85 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6541STOCK Price

Open 63.00 Change Price %
High 65.50 1 Day -4.70 -7.42
Low 58.60 1 Week 4.00 7.33
Close 58.60 1 Month 0.60 1.03
Volume 3972373 1 Year -7.50 -11.35
52 Week High 81.80 | 52 Week Low 48.10
 
TW Taiwan Most Active Stocks
2888 11.80 3.96%
2344 67.50 -5.33%
1802 38.25 -4.14%
8110 49.25 2.82%
2337 37.00 -4.52%
2485 25.85 -6.17%
2883 16.40 0.61%
8021 151.50 9.78%
1303 61.40 -1.13%
8039 95.70 1.81%
 
TW Taiwan Top Gainers Stocks
6443 16.50 10.00%
3092 16.50 10.00%
2402 67.10 10.00%
6456 47.50 9.95%
2441 79.70 9.93%
2424 38.80 9.92%
2349 11.65 9.91%
2349 11.65 9.91%
3296 22.75 9.90%
4927 27.80 9.88%
 
TW Taiwan Top Losers Stocks
6289 1.35 -10.00%
2612 61.60 -7.51%
6541 58.60 -7.42%
3706 87.90 -6.89%
8103 85.60 -6.65%
8103 85.60 -6.65%
2314 22.50 -6.64%
2314 22.50 -6.64%
4739 70.90 -6.46%
2485 25.85 -6.17%
 
 
6541
Daily Charts
6541
Intraday Charts
Whats New @
Bazaartrend
6541
Free Analysis
 
6541 Important Levels Intraday
RESISTANCE71.90
RESISTANCE67.63
RESISTANCE65.00
RESISTANCE62.36
SUPPORT54.84
SUPPORT52.20
SUPPORT49.57
SUPPORT45.30
 
6541 Forecast December 2025
4th UP Forecast77.68
3rd UP Forecast71.56
2nd UP Forecast67.78
1st UP Forecast64
1st DOWN Forecast53.2
2nd DOWN Forecast49.42
3rd DOWN Forecast45.64
4th DOWN Forecast39.52
 
6541 Weekly Forecast
4th UP Forecast77.29
3rd UP Forecast71.30
2nd UP Forecast67.59
1st UP Forecast63.89
1st DOWN Forecast53.31
2nd DOWN Forecast49.61
3rd DOWN Forecast45.90
4th DOWN Forecast39.91
 
6541 Forecast2025
4th UP Forecast123.93
3rd UP Forecast102.98
2nd UP Forecast90.03
1st UP Forecast77.08
1st DOWN Forecast40.12
2nd DOWN Forecast27.17
3rd DOWN Forecast14.22
4th DOWN Forecast-6.73
 
 
6541 Other Details
Segment EQ
Market Capital 17741051904.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6541 Address
6541
 
6541 Latest News
 
Your Comments and Response on Tanvex BioPharma Inc
 
6541 Business Profile
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. The company's lead product candidate includes TX01 for the treatment of neutropenia. It also develops TX05, which has completed phase III clinical trial for the treatment of breast cancer; TX04 for the treatment of neutropenia; TX16 that has completed phase I clinical trial for the treatment of metastatic colorectal cancer; TX52, which is in pre-clinical trial; and other products. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Address: 802 West Bay Road, George Town, Cayman Islands, KY1-1205
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service